This profile of the drug use is consistent with international recommendations for the clinical use of the drug, as to encourage prescribing for patients with a diagnosis of UTI, for 2 days of treatment, and concomitantly with an antibiotic to resolve the ITU1, However, in contrast to the above, it is unfortunate that 11% of patients diagnosed with UTI, were not prescribed an antimicrobial agent.
Este perfil de utilización del medicamento concuerda con las recomendaciones internacionales para uso clínico del fármaco, en cuanto a favorecer su prescripción para los pacientes con diagnóstico de ITU, por 2 días de tratamiento, y de forma concomitante con un antibiótico para resolver la ITU1, .